Dated disclosed rounds · latest 2024-08-01
Later stage / growth
Healx
AI drug discovery (rare disease); AI drug discovery (rare disease) — borderline biotech/healthtech
VerifiedSeries CCambridge
- Companies House
- 09018507
- GLEIF LEI
- Not matched
- Latest evidence
- 2024-08-01
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-25T03:32:12.583Z
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
3 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
FundingSource fact Series C
$47M / £37M · 9 named investors
RegistryRegistry fact Company incorporated
HEALX LIMITED · company 09018507
Latest disclosed round
Series C
- Date
- 2024-08-01
- Amount
- USD 47m
- Sector
- Biotech & techbio; Healthtech & digital health
- Companies House
- 09018507
- ONS region
- East
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
10 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
AtomicoleadR42 GroupleadAyana CapitalparticipantBalderton Capitalparticipantbtov PartnersparticipantGlobal BrainparticipantJonathan Milnerparticipanto2hparticipanto2h VenturesparticipantVU Venture Partnersparticipant
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| Atomico | lead | 2024-08-01 | TechCrunch ↗ · UKTN ↗ · Healx ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| R42 Group | lead | 2024-08-01 | TechCrunch ↗ · UKTN ↗ · Healx ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Ayana Capital | participant | 2024-08-01 | TechCrunch ↗ · UKTN ↗ · Healx ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Balderton Capital | participant | 2024-08-01 | TechCrunch ↗ · UKTN ↗ · Healx ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| btov Partners | participant | 2024-08-01 | TechCrunch ↗ · UKTN ↗ · Healx ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Global Brain | participant | 2024-08-01 | TechCrunch ↗ · UKTN ↗ · Healx ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Jonathan Milner | participant | 2024-08-01 | TechCrunch ↗ · UKTN ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| o2h | participant | 2024-08-01 | TechCrunch ↗ · UKTN ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| o2h Ventures | participant | 2024-08-01 | Healx ↗ · UKTN ↗ · Finsmes ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| VU Venture Partners | participant | 2024-08-01 | TechCrunch ↗ · UKTN ↗ · Healx ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
1 disclosed round
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2024-08-01 | Series C | $47M / £37M | R42 Group · Atomico · Balderton · Jonathan Milner · Global Brain · Ayana Capital · 1 additional source-listed name · + 2 more linked | TechCrunch ↗ · UKTN ↗ · Healx ↗ |
Companies House status and filing snapshot
HEALX LIMITED
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2014-04-30
- Dissolved
- Not applicable
- Company number
- 09018507
Filing context
- Accounts category
- GROUP
- Accounts made up to
- 2024-12-31
- Next accounts due
- 2026-09-30
- Confirmation made up to
- 2026-04-30
- Registry snapshot
- 2026-08-01
- Live check
- 2026-08-25T03:32:12.583Z
Former registered names: HEALX3 LIMITED
74909Other professional, scientific and technical activities n.e.c.
CompanyBeacon statutory projection
HEALX LIMITED
UK Capital Intelligence owns the capital view on this page. CompanyBeacon owns the exact legal-entity, filing, control and public-record timeline for company number 09018507.
Latest retained status
active
- Checked
- 2026-08-25T03:32:12.583Z
- Recorded change
- No change timestamp retained
- Previous status
- active
- Fund associations
- 3 dated CompanyBeacon memberships
Boundary
Verify the legal record
Fund association does not prove a current holding. Status change is a review signal, not investment performance or wrongdoing. Ownership and control are not copied into this public UKCI package.
Open CompanyBeacon record ↗Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.